Skip to main content

and
  1. Article

    Open Access

    ABO blood types and sepsis mortality

    We aimed to determine if the ABO blood types carry different risks of 30-day mortality, acute kidney injury (AKI), and endothelial damage in critically ill patients with sepsis. This was a retrospective cohort...

    Theis S. Itenov, Daniel I. Sessler, Ashish K. Khanna in Annals of Intensive Care (2021)

  2. Article

    Open Access

    High frequencies of circulating memory T cells specific for calreticulin exon 9 mutations in healthy individuals

    Mutations in exon 9 of the calreticulin gene (CALR) frequently occur in patients with chronic myeloproliferative neoplasms (MPN). Patients exhibit spontaneous cellular immune responses to epitopes derived from th...

    Morten O. Holmström, Shamaila M. Ahmad, Uffe Klausen in Blood Cancer Journal (2019)

  3. Article

    Open Access

    Prediction of non-recovery from ventilator-demanding acute respiratory failure, ARDS and death using lung damage biomarkers: data from a 1200-patient critical care randomized trial

    It is unclear whether biomarkers of alveolar damage (surfactant protein D, SPD) or conductive airway damage (club cell secretory protein 16, CC16) measured early after intensive care admittance are associated ...

    Jens-Ulrik S. Jensen, Theis S. Itenov, Katrin M. Thormar in Annals of Intensive Care (2016)

  4. Article

    Open Access

    Long-lasting disease stabilization in the absence of toxicity in metastatic lung cancer patients vaccinated with an HLA-A2-restricted epitope derived from indoleamine 2,3 dioxygenase

    Trine Z Iversen, Lotte Engell-Noerregaard in Journal for ImmunoTherapy of Cancer (2013)

  5. Article

    Open Access

    Survivin-specific T-cell reactivity correlates with tumor response and patient survival: a phase-II peptide vaccination trial in metastatic melanoma

    Therapeutic vaccination directed to induce an anti-tumoral T-cell response is a field of extensive investigation in the treatment of melanoma. However, many vaccination trials in melanoma failed to demonstrate...

    Jürgen C. Becker, Mads H. Andersen in Cancer Immunology, Immunotherapy (2012)

  6. Article

    Open Access

    The Procalcitonin And Survival Study (PASS) – A Randomised multi-center investigator-initiated trial to investigate whether daily measurements biomarker Procalcitoninand pro-active diagnostic and therapeutic responses to abnormal Procalcitonin levels, can improve survival in intensive care unit patients. Calculated sample size (target population): 1000 patients

    Sepsis and complications to sepsis are major causes of mortality in critically ill patients. Rapid treatment of sepsis is of crucial importance for survival of patients. The infectious status of the critically...

    Jens-Ulrik Jensen, Bettina Lundgren, Lars Hein, Thomas Mohr in BMC Infectious Diseases (2008)

  7. No Access

    Article

    Immunological tumor destruction in a murine melanoma model by targeted LTα independent of secondary lymphoid tissue

    We previously demonstrated that targeting lymphotoxin α (LTα) to the tumor evokes its immunological destruction in a syngeneic B16 melanoma model. Since treatment was associated with the induction of peritumor...

    David Schrama, Heike Voigt, Andreas O. Eggert in Cancer Immunology, Immunotherapy (2008)

  8. No Access

    Article

    Complete remission of liver metastasis of pancreatic cancer under vaccination with a HLA-A2 restricted peptide derived from the universal tumor antigen survivin

    Purpose: As prognosis of advanced pancreatic cancer remains gloomy, novel therapeutic modalities have to be developed. Immunotherapy, which targets tumor-associated antigens of tumor cells or tumor stroma, is cur...

    Marion Wobser, Petra Keikavoussi, Volker Kunzmann in Cancer Immunology, Immunotherapy (2006)